The global medical devices industry experienced a 15% drop in social media posts on nanomedicine in Q1 2023 compared with the previous quarter, with the highest share accounted for Neuralink, according to GlobalData’s analysis of social media posts. GlobalData’s Nanotechnology in Medicine – Thematic Research report focuses on nanotechnology and nanomedicines that are currently approved by the FDA, the leading public and private companies associated with the nanotechnology in medicine theme, and the primary ways in which the theme impacts the medical devices i Buy the report here.
Notably, artificial intelligence was one of the most frequently referenced themes in Q1 2023, ranking highest in terms of mentions ahead of internet of things and innovation, according to GlobalData.
Of the 50 leading companies in the medical devices industry, Neuralink had the most mentions of nanomedicine in Q1 2023. GlobalData identified 226 nanomedicine-related posts in the industry's social media activity - 0.48% of all posts - and a decrease of 15% in Q1 2023 compared with Q4 2022.
For further understanding of GlobalData's Nanotechnology in Medicine - Thematic Research, buy the report here.